Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary diseases causing kidney calculi]

P Cochat1, M Jouvenet, H Pellet

  • 1Unité de néphrologie pédiatrique, Hôpital Edouard-Herriot, Lyon.

La Revue Du Praticien
|November 20, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Factors influencing the acceptability of pediatric galenic formulations].

Annales pharmaceutiques francaises·2018
Same author

Pediatric renal transplantation: A retrospective single-center study on epidemiology and morbidity due to EBV.

Pediatric transplantation·2018
Same author

[Renal abnormalities in Down syndrome: A review].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017
Same author

Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins: A role for maternal alendronate therapy before pregnancy or antireflux medications?

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2016
Same author

Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.

Arthritis & rheumatology (Hoboken, N.J.)·2016
Same author

Oral drug dosage forms administered to hospitalized children: Analysis of 117,665 oral administrations in a French paediatric hospital over a 1-year period.

International journal of pharmaceutics·2016
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Hereditary kidney stone diseases, including idiopathic hypercalciuria and cystinuria, require prompt physician awareness. Early diagnosis and specific management are crucial for long-term renal health and therapeutic compliance.

Area of Science:

  • Nephrology
  • Medical Genetics

Context:

  • Hereditary kidney stone diseases (urolithiasis/nephrocalcinosis) are rare but significant conditions.
  • These conditions affect both pediatric (10-40% of lithiases) and adult (less than 15%) populations.
  • Specific management is essential due to the underlying genetic basis.

Purpose:

  • To highlight the importance of recognizing hereditary causes of kidney stones.
  • To outline common hereditary stone-forming disorders.
  • To emphasize diagnostic and management strategies.

Summary:

  • Frequent hereditary disorders include idiopathic hypercalciuria, distal tubular acidosis, cystinuria, and hyperoxaluria.
  • Stone formation results from increased urinary concentrations of calcium, oxalate, phosphate, cystine, or xanthine.

Related Experiment Videos

  • Infrared spectrophotometry is key for stone composition analysis; biochemical tests are alternatives.
  • Management involves high fluid intake, potential alkalinization, and specific therapeutic procedures.

    • Impact:

    • Early identification and tailored treatment improve long-term renal prognosis.
    • Physician awareness of these rare conditions is critical for timely intervention.
    • Patient adherence to therapy significantly influences outcomes in hereditary stone disease.